Skip to content
buyWeak

Jorey Chernett bought $57k of STLN

owner at Oncology Institute, Inc.. 12,000 shares at an average of $4.75, traded Jun 4, 2026, filed Jun 5, 2026.

Conviction score
14
Value
$57k
12,000 shares
Holdings after
10,579,858
+0% from before
From 52-week low
+131%
low $2.05, close $4.74
From 52-week high
-1%
high $4.78, as of Jun 4, 2026

Score components

  • Role
    10% owner
    +12
  • Trade size
    $57k at market
    +7
  • Relative to holdings
    Under 1% of holdings (0.1%)
    -5
  • Price context
    Near the top of the 52-week range
    0
  • Cluster
    No other insider buying within 14 days
    0
  • Repeat buying
    9 buys in 90 days
    +5
  • Track record
    Too few past buys to judge (0 with prices)
    0
  • Outside holder
    A 10% owner who is not an officer or director
    -5

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

STLNOct 12, 2026 · close 6.92
Since filing Jun 5, 2026: +42.1%SPY +6.0% · excess +36.1%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0000921895-26-001564, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Jun 4, 2026POpen-market purchase
Common Stock
+12,000$4.75$57k10,579,858Jun 5, 2026

Related signals

Other insiders at Oncology Institute, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
30Weak
STLNsell10b5-1
Oncology Institute, Inc.
Brad Hively
director
$1.9M
298,853 shares
-42%
26Weak
STLNbuy
Oncology Institute, Inc.
Jorey Chernett
owner
$78k
12,000 shares
+0%
27Weak
STLNbuy
Oncology Institute, Inc.
Jorey Chernett
owner
$95k
18,000 shares
+0%
0Weak
STLNsell10b5-1
Oncology Institute, Inc.
Yale Podnos
Chief Medical Officer
$150k
23,452 shares
-8%
26Weak
STLNbuy
Oncology Institute, Inc.
Jorey Chernett
owner
$88k
15,000 shares
+0%
16Weak
STLNbuy
Oncology Institute, Inc.
Jorey Chernett
owner
$90k
18,000 shares
+0%
6Weak
STLNsell10b5-1
Oncology Institute, Inc.
Yale Podnos
Chief Medical Officer
$126k
23,451 shares
-8%
18Weak
STLNbuy
Oncology Institute, Inc.
Jorey Chernett
owner
$157k
38,500 shares
+0%
17Weak
STLNbuy
Oncology Institute, Inc.
Jorey Chernett
owner
$123k
30,000 shares
+0%
20Weak
STLNsell10b5-1
Oncology Institute, Inc.
Mohit Kaushal
director
$335k
95,719 shares
-36%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Jorey Chernett bought $57k of STLN | InsiderTell